Handa Pharmaceuticals, Inc.

Handa Pharmaceuticals, Inc.verified

6620.TWO

Price:

$95.5

Market Cap:

$15.03B

Handa Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development of drugs for various diseases in the United States and China. The company provides Quetiapine XR for the treatment of Schizophrenia; and Dexlansoprazole DR capsules. It also develops ONCORE, a proprietary drug delivery technology that was developed to improve the patient compliance and safety of the tyrosine kinase inhibitor of oncology drugs; 505(b)(2)NDA, a therapeutic product; Tascenso ODT for the treatment of multiple sclerosis; and HND-033 and HND-027, an oncology products. In addition, the company develops HND-004, a diabetic drug; HND-032 for smoking cessation; and HND-026, a GI drug. Handa Pha...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2016-12-30

Stock Exchange

TWO

Ticker

6620.TWO

The Enterprise Value as of December 2025 (TTM) for Handa Pharmaceuticals, Inc. (6620.TWO) is 14.16B

According to Handa Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 14.16B. This represents a change of 7.65% compared to the average of 13.16B of the last 4 quarters.

Handa Pharmaceuticals, Inc. (6620.TWO) Historical Enterprise Value (quarterly & annually)

How has 6620.TWO Enterprise Value performed in the past?

The mean historical Enterprise Value of Handa Pharmaceuticals, Inc. over the last ten years is 10.43B. The current 14.16B Enterprise Value has changed 13.49% with respect to the historical average. Over the past ten years (40 quarters), 6620.TWO's Enterprise Value was at its highest in in the March 2023 quarter at 24.83B. The Enterprise Value was at its lowest in in the September 2024 quarter at 8.98B.

Quarterly (TTM)
Annual

Average

10.43B

Median

8.89B

Minimum

2.55B

Maximum

23.99B

Handa Pharmaceuticals, Inc. (6620.TWO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Handa Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 206.91%

Maximum Annual Enterprise Value = 23.99B

Minimum Annual Increase = -58.46%

Minimum Annual Enterprise Value = 2.55B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20249.96B-58.46%
202323.99B60.68%
202214.93B90.89%
20217.82B206.91%
20202.55B-22.65%

Handa Pharmaceuticals, Inc. (6620.TWO) Average Enterprise Value

How has 6620.TWO Enterprise Value performed in the past?

The current Enterprise Value of Handa Pharmaceuticals, Inc. (6620.TWO) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

16.30B

5-year avg

11.85B

10-year avg

10.43B

Handa Pharmaceuticals, Inc. (6620.TWO) Enterprise Value vs. Peers

How is 6620.TWO’s Enterprise Value compared to its peers?

Handa Pharmaceuticals, Inc.’s Enterprise Value is less than Grape King Bio Ltd (15.82B), less than TTY Biopharm Company Limited (20.51B), less than Synmosa Biopharma Corporation (17.65B), less than Alar Pharmaceuticals Inc. (16.50B), less than YungShin Global Holding Corporation (15.18B), greater than ScinoPharm Taiwan, Ltd. (11.80B), less than Sunmax Biotechnology Co., Ltd. (20.88B), less than Great Tree Pharmacy Co., Ltd. (19.48B), less than TaiMed Biologics Inc. (16.98B), less than EirGenix Inc. (17.64B),

Build a custom stock screener for Handa Pharmaceuticals, Inc. (6620.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Handa Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Handa Pharmaceuticals, Inc. (6620.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Handa Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Handa Pharmaceuticals, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Handa Pharmaceuticals, Inc. (6620.TWO)?

What is the 3-year average Enterprise Value for Handa Pharmaceuticals, Inc. (6620.TWO)?

What is the 5-year average Enterprise Value for Handa Pharmaceuticals, Inc. (6620.TWO)?

How does the current Enterprise Value for Handa Pharmaceuticals, Inc. (6620.TWO) compare to its historical average?